Opinion & analysis

Accenture Prescribes A New Data Management Future For Medtechs

In Vivo examines efforts by Accenture Life Sciences to survey medtech CEOs on their digital preparedness as leaders look to build new revenue streams from innovative business models by effectively managing data. Discover what trends they uncovered in this illuminating article from In Vivo.

Accenture Prescribes A New Data Management Future For Medtechs

Adaptive Clinical Trial Designs: US FDA Provides Checklist To Begin Study

AHPA Backs NDI Filing For Kratom, Experts Question FDA Enforcement

Amarin CEO Thero On Gearing Up For Success Ahead Of The Big Vascepa Ad Comm

Amarin CEO: Consumers Have Heard About Omega-3 Heart Benefits ‘Too Long’

An FDA Age-Based Predicate Policy Would Be Arbitrary, Reg Experts Complain

Analysts Weigh Up Benefits Of Big Bayer Restructuring

Annuity Payment Model For Cures May Get Test Drive In Massachusetts

Anti-Aging Cosmetics Or Unlawfully Marketed Drugs? Two Federal Court Cases To Watch

As Humira Biosimilars Arrive, Battle Lines Shift From Education To Sustainability

ASCO 2018: Optimism As Industry Resets And Looks To What Is Next

Bayer’s Consumer Chief Initiates Turnaround Plan In Bid To Return Troubled Business To Growth

Bayer’s US Playbook: The Smart Way To Top-Line Growth

Behind The Scenes Of Digital Health: Medtech Players And Partners

Benefit-Risk Is Front-And-Center In Latest Revision Of International Risk Management Standard ISO 14971